![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 403/14 | (2006.01) |
C07D 403/14 | (2013.01) | ||
C07D 401/14 | (2006.01) | ||
C07D 401/14 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 31/4709 | (2006.01) |
(11) | Number of the document | 3795570 |
(13) | Kind of document | T |
(96) | European patent application number | 20177662.2 |
Date of filing the European patent application | 2020-06-01 | |
(97) | Date of publication of the European application | 2021-03-24 |
(45) | Date of publication and mention of the grant of the patent | 2022-02-23 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201962904007 P | 2019-09-23 | US |
(72) |
FAN, Jie , US
QIAN, Yimin , US
HE, Wei , US
LIU, Ke , US
|
(73) |
Accutar Biotechnology Inc. ,
760 Parkside Avenue
Room 213, Brooklyn, NY 11226,
US
|
(54) | SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF |
SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF |